{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T18:59:36Z","timestamp":1773860376824,"version":"3.50.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.crohns.2011.09.011","type":"journal-article","created":{"date-parts":[[2011,10,20]],"date-time":"2011-10-20T00:38:50Z","timestamp":1319071130000},"page":"419-424","source":"Crossref","is-referenced-by-count":49,"title":["Corticosteroids and immunosuppressive therapy influence the result of QuantiFERON TB Gold testing in inflammatory bowel disease patients"],"prefix":"10.1093","volume":"6","author":[{"given":"Ulf","family":"Helwig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Hedderich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.crohns.2011.09.011_bb0005","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1136\/gut.2005.081950b","article-title":"European evidence based consensus on the diagnosis and management of Crohn's disease: current management","volume":"55","author":"Travis","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2011.09.011_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clim.2007.08.012","article-title":"TNFalpha blockade in human diseases: an overview of efficacy and safety","volume":"126","author":"Lin","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.crohns.2011.09.011_bb0015","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.berh.2006.06.002","article-title":"Problems encountered during anti-tumour necrosis factor therapy","volume":"20","author":"Desai","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.crohns.2011.09.011_bb0020","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crohns.2011.09.011_bb0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)60078-6","article-title":"Disseminated tuberculosis after anti-TNFalpha treatment","volume":"369","author":"Malipeddi","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.crohns.2011.09.011_bb0030","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1055\/s-2008-1027796","article-title":"Clinical practice guideline on diagnosis and treatment of Crohn's disease","volume":"46","author":"Hoffmann","year":"2008","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.crohns.2011.09.011_bb0035","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1055\/s-2004-813510","article-title":"Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease","volume":"42","author":"Hoffmann","year":"2004","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.crohns.2011.09.011_bb0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1086\/426434","article-title":"Influence of bacille Calmette-Guerin vaccination on size of tuberculin skin test reaction: to what size?","volume":"40","author":"Tissot","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.crohns.2011.09.011_bb0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1542-3565(04)00060-6","article-title":"High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy","volume":"2","author":"Mow","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2011.09.011_bb0050","doi-asserted-by":"crossref","unstructured":"Dyrhol-Riise AM, Gran G, Wenzel-Larsen T, Blomberg B, Haanshuus CG, Morkve O. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis;10:57.","DOI":"10.1186\/1471-2334-10-57"},{"key":"10.1016\/j.crohns.2011.09.011_bb0055","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10096-008-0519-1","article-title":"Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment","volume":"27","author":"Bocchino","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.crohns.2011.09.011_bb0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2334-10-57","article-title":"Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country","volume":"10","author":"Dyrhol-Riise","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"Suppl. 5","key":"10.1016\/j.crohns.2011.09.011_bb0065","doi-asserted-by":"crossref","first-page":"V1","DOI":"10.1136\/gut.2004.043372","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"53","author":"Carter","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2011.09.011_bb0070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10238-009-0082-9","article-title":"Comparison of tuberculin skin test and QuantiFERON-TB gold in tube test in patients with chronic inflammatory diseases living in a tuberculosis endemic population","volume":"10","author":"Gogus","year":"2010","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.crohns.2011.09.011_bb0075","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.3899\/jrheum.090268","article-title":"Agreement between Quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"36","author":"Inanc","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.crohns.2011.09.011_bb0080","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/rheumatology\/kem252","article-title":"Comment on: Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-alpha agents: the Newcastle (UK) experience","volume":"46","author":"Kaushik","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.crohns.2011.09.011_bb0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ibd.21427","article-title":"Factors impacting the results of interferon-gamma release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases","volume":"17","author":"Papay","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2011.09.011_bb0090","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.1572-0241.2008.02050.x","article-title":"Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease","volume":"103","author":"Schoepfer","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2011.09.011_bb0095","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/gut.31.5.529","article-title":"T-cellular immune reactions (in macrophage inhibition factor assay) against Mycobacterium paratuberculosis, Mycobacterium kansasii, Mycobacterium tuberculosis, Mycobacterium avium in patients with chronic inflammatory bowel disease","volume":"31","author":"Seldenrijk","year":"1990","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2011.09.011_bb0100","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2249.1995.tb03837.x","article-title":"Peripheral cell-mediated immune response to mycobacterial antigens in inflammatory bowel disease","volume":"102","author":"Rowbotham","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.crohns.2011.09.011_bb0105","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0889-8553(21)00036-4","article-title":"Cell-mediated immune injury in the intestine","volume":"21","author":"MacDonald","year":"1992","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.crohns.2011.09.011_bb0110","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/ibd.20496","article-title":"Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy","volume":"14","author":"Zabana","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2011.09.011_bb0115","first-page":"83","article-title":"Bericht zur Epidemiologie der Tuberkulose in Deutschland f\u00fcr 2008","volume":"11","author":"The Robert Koch Institute","year":"2009","journal-title":"Epidemiologisches Bulletin"},{"key":"10.1016\/j.crohns.2011.09.011_bb0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ibd.21329","article-title":"QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States","volume":"17","author":"Qumseya","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2011.09.011_bb0125","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1365-2362.2011.02502.x","article-title":"Predictors of indeterminate IFN-gamma release assay in screening for latent TB in inflammatory bowel diseases","volume":"41","author":"Papay","year":"2011","journal-title":"Eur J Clin Invest"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994611002613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994611002613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/6\/4\/419\/1177836\/6-4-419.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T22:32:18Z","timestamp":1639261938000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2011.09.011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1873994611002613"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2011.09.011","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}